Keeping up with the science: Innovation in the health and care system post Brexit
Article
Innovation in health – new treatments, technologies and processes – can help drive improvements in healthcare and ultimately health outcomes. We are on the cusp of a new wave of innovation driven by robotics, big data and therapeutic breakthroughs such as cell and gene therapy.
However, the history of innovation in the UK shows that the health and care system is often slow to adopt new technologies. The government has tried to address the causes of this problem, most recently through the Accelerated Access Review (AAR) and Life Sciences (Industrial) Strategy.
Although these initiatives offer a number of sensible policy suggestions, the reality is that they will fail to deliver on their potential without a Brexit deal that prioritises health and care; a new long-term funding settlement for health and care; and a clear plan for system reform in the NHS.
Related items

Rule of the market: How to lower UK borrowing costs
The UK is paying a premium on its borrowing costs that ‘economic fundamentals’, such as the sustainability of its public finances, cannot fully explain.
Restoring security: Understanding the effects of removing the two-child limit across the UK
The government’s decision to lift the two-child limit marks one of the most significant changes to the social security system in a decade.
Building a healthier, wealthier Britain: Launching the IPPR Centre for Health and Prosperity
Following the success of our Commission on Health and Prosperity, IPPR is excited to launch the Centre for Health and Prosperity.